Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:303-304 (4 February), doi:10.1136/bmj.332.7536.303-b
| The first 150 words of the full text of this article appear below. |
EDITORAnticoagulation is underused in the treatment of non-valvular atrial fibrillation. Choudhry et al show that adverse outcomes from anticoagulation have greater influence on its management than occurrences of avoidable ischaemic stroke.1 They speculate that this result arises from undue fear or concern about adverse consequences of anticoagulation.
We are conducting a representative national survey of 1000 Australian general practitioners, addressing how fear of anticoagulation affects management of non-valvular atrial fibrillation. Our preliminary findings indicate that aversion to the risk of intracranial haemorrhage is substantial. Doctors are overly cautious in prescribing anticoagulation where there is a perceived risk of major and even minor bleeding even when the benefits of anticoagulation outweigh the risks.
In 207 early responses, 95 doctors reported the experience of an ischaemic stroke in their patients with non-valvular atrial fibrillation without anticoagulation. Only 27 reported experiencing an intracranial haemorrhage in such patients receiving anticoagulants. Over half
Melina Gattellari, research fellow
General Practice Unit, School of Public Health and Community Medicine, University of New South Wales, Kensington, NSW 2052, Australia Melina.Gattellari@sswahs.nsw.gov.au
Nicholas A Zwar, director
General Practice Unit, School of Public Health and Community Medicine, University of New South Wales, Kensington, NSW 2052, Australia
John M Worthington, senior staff specialist in neurology
Liverpool Health Service. Locked Bag 7017, Liverpool, NSW 1871
Sandy Middleton, professor of nursing
School of Nursing (NSW), ACU National, PO Box 968, North Sydney, NSW 2059